Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,798,447 papers from all fields of science
Search
Sign In
Create Free Account
Alphagan
Known as:
Alphagan®
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Alphagan P
Brimonidine tartrate 1.5 MG/ML Ophthalmic Solution [Alphagan]
Broader (2)
Brimonidine tartrate
brimonidine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE ( 58 ) Field of Classification Search None
Lorenz Siddiqi
2017
Corpus ID: 53543087
, 15 ( 1 ) . Data Sheet for Brimonidine , 2007 , 1 Page . Data Sheet for Timolol , 2007 , 1 Page . David , Robert et al…
Expand
2014
2014
Síndrome de Charles Bonnet desencadenado por brimonidina en paciente con neuropatía óptica hereditaria de Leber
E. Santos-Bueso
,
F. Saénz-Francés
,
J. Porta‐Etessam
,
J. García‐Sánchez
2014
Corpus ID: 205013007
Review
2014
Review
2014
Current Preferred Agents: BETAXOLOL, BRIMONIDINE (ALPHAGAN AND ALPHAGAN P), BRINZOLAMIDE (AZOPT), CARTEOLOL. DORZOLAMIDE/TIMOLOL, LATANOPROST, PILOCARPINE GEL AND DROPS, and TRAVOPROST (TRAVATAN Z…
2014
Corpus ID: 16986178
Background: The first goal of medical therapy in glaucoma is to reduce intraocular pressure (IOP), and the fixed-combination…
Expand
2008
2008
Efficacy of brimonidine tartrate 0.2% ophthalmic solution in reducing halos after laser in situ keratomileusis
Ji Hoon Lee
,
Y. You
,
C. Choe
,
Eun Suk Lee
Journal of cataract and refractive surgery
2008
Corpus ID: 6174706
Highly Cited
2005
Highly Cited
2005
Alphagan allergy may increase the propensity for multiple eye-drop allergy
Sally E. Osborne
,
Dm Montgomery
,
D. Morris
,
IC McKay
Eye
2005
Corpus ID: 19756303
Aims Since its introduction in 1996, brimonidine tartrate 0.2% ophthalmic solution (Alphagan, Allergan) twice daily has become…
Expand
Review
2004
Review
2004
Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan®) in children
R. J. C. Bowman
,
R. Bowman
,
J. Cope
,
K. Nischal
,
K. Nischal
Eye
2004
Corpus ID: 23994638
AbstractIntroduction Brimonidine 0.2% (Alphagan®) is a topical alpha-2 agonist widely used as an antihypertensive. There have…
Expand
2003
2003
Miotic effect of alphagan P.
W. Faulkner
Journal of cataract and refractive surgery
2003
Corpus ID: 28987198
2002
2002
Formulation effects on ocular absorption of brimonidine in rabbit eyes.
A. Acheampong
,
D. Small
,
V. Baumgarten
,
D. Welty
,
D. Tang-Liu
Journal of Ocular Pharmacology and Therapeutics
2002
Corpus ID: 20350383
Purite (stabilized oxychloro complex) and benzalkonium chloride (BAK) are preservatives. We investigated formulation effects on…
Expand
2001
2001
Quantitation of mitomycin C in human ocular tissues by high-performance liquid chromatography-photo-diode array detection.
X. Xiong
,
B. Lim
,
M. Lat-Luna
,
P. Chew
,
D. Tan
Journal of Chromatography B: Biomedical Sciences…
2001
Corpus ID: 41330302
2000
2000
A case of suspected alphagan-induced psychosis.
D. D. Kim
A M A Archives of Ophthalmology
2000
Corpus ID: 41085524
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE